Evening Engager, Hosted by Foundation Medicine

This session will bring together precision medicine experts to discuss how the latest generation of biomarkers are driving smarter trial enrollment and monitoring.

Enjoy dinner, networking, and a panel discussion on opportunities for emerging biomarkers to impact clinical trial design.

Speakers:

Steffan Ho

Vice President & Head of Translational Oncology

Pfizer

Jason Adams

Vice President & Head of Biopharma Business Development

Foundation Medicine

Brennan Decker

Senior Pathologist, Associate Medical Director, Director of Clinical Biomarkers

Foundation Medicine

David Weingeist

Scientific Director, Oncology Precision Medicine & Diagnostics

Johnson & Johnson

Fernando Cruz-Guilloty

Scientific Director, Oncology - Precision Medicine & Diagnostics Lead

Johnson & Johnson Innovative Medicine